ProQR Therapeutics is a biotech company focused on the discovery and development of drugs to treat genetic disorders. Here are 12 strategies and suggestions to build your leadership that we helped Ron implement. Shape Therapeutics is . Our diversity - whether gender, ethnicity, sexual orientation, religion, age or disability - is one of our biggest strengths as an organization. Enter employee name to find & verify emails, phones, social links, etc. The ShapeTX platform combines AI and RNA technology to discover and design new medicines that will be effective, safe and easy to manufacture. We have to be creative; we need to transform the paradigm. Get Contact Info for All Departments Shape Therapeutics, Inc. Org Chart John Suliman Co-Founder 5 4 Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. our sites and services. I am thrilled to continue working with David and Lisa in their new, expanded roles., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. [email protected], 1985 - 2023 BioSpace.com. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. free lookups / month. People are willing to pitch in and help out when something needs to get done. Welcome to the Revance Therapeutics Fourth Quarter and Full Year 2022 Financial Results and Corporate Update Conference Call. Discover current leadership team members including founders, CEO, other executives and board directors. ", Im here to bring genetic medicine to life. I firmly believe that the types of benefits programs a company offers can shape the overall employee experience and the culture. No credit card required. Angela J. Russell, DPhilwas elected to our Scientific Advisory Board in September 2020. Operating Status Active. million verified professionals across 35 million companies. Shape Life! Chief Business Officer, Will Krause By continuing to use this site you are consenting to these choices. Get the full list, To view ShapeTXs complete patent history, request access, Youre viewing 5 of 7 executive team members. ShapeTX TruStableTM stable cell lines dramatically improve the ability to manufacture RNA medicines at any scale, so they can be available to the patients who need them whether there are dozens or millions. Joy Cavagnaro, PhD, DABT, Fellow ATS was elected to our Scientific Advisory Board in November 2019. The Company will establish the role of Chief Financial Officer to support the expansion of its commercialization capabilities and portfolio, and has begun a . Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all. San Diego - November 1, 2021 - Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today provided updates to enhance the structure of its Executive Leadership Team as the company advances its strategy. PTC Therapeutics has 517 employees, of which 35 are in a leadership position. Im thrilled to join such a talented team of innovative thinkers. Get the full list, Youre viewing 5 of 10 investors. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. About. The Shape Therapeutics, Inc. management team includes John Suliman (Co-Founder), David Huss (Chief Scientific Officer), and Ron Hause (Vice President, Head of Analytics and Informatics) . Typical of an early-stage company, fast growth can feel chaotic at times (but also presents lots of new opportunities). During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. ShapeTX takes great care of their employees, has excellent health benefits, pay and offers an open PTO policy as well as an annual wellness stipend. Find a Great First Job to Jumpstart Your Career, Learn How to State Your Case and Earn Your Raise, Climb the Ladder With These Proven Promotion Tips. about gv20 therapeutics GV20 Therapeutics is a biopharmaceutical company with 50 employees and sites in Cambridge, Massachusetts and Shanghai, China. At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. Explore {Shape Therapeutics's key management people. Dr. Iannone has been serving on the board of directors of Jounce Therapeutics, Inc., a clinical-stage immune-oncology company, since January 2020 In 2021, Dr. Iannone was . Ms. Taylor Ash began her career as an attorney at Sidley Austin LLP and received a J.D. July 15, 2021 08:00 ET Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. Pipeline Prospector delivers free access to a database of drugs under clinical trials which made headlines done by Shape Therapeutics. Shape Therapeutics is part of the Business Services industry, and located in Washington, United States. Analyst Briefing Submitters are 7x more likely to receive a qualified connection. Shape Therapeutics is a development-stage biotechnology company. Shape Life! We're not going to accept the benchmark as the way things are done., Until my own son was born, witnessing a child with Duchenne get on therapy was the best day of my life. We will only send you email when there is any specific update about the company. They seem respectful towards one another. Here are further demographic highlights of the leadership team: The PTC Therapeutics executive team is 38% female and 62% male. Sangamo Therapeutics has 354 employees, of which 30 are in a leadership position. Interested in researching Shape Therapeutics? ShapeTX is committed to data-driven scientific advancement, passionate people and a mission of providing life-long cures to patients. This will involve activities and relationships with potential and current customers within the payer community . Existing Subscriber? We have this culture of innovating. Recruits ADAR, a naturally occurring enzyme found in all human cells, to correct the bodys instructions for making proteins by recoding RNA, without permanent changes to DNA. We deploy the Shape TX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. Copyright 2023 CB Information Services, Inc. All rights reserved. Shape Therapeutics Inc. Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. Up to 5 See what employees say it's like to work at Shape Therapeutics. The ShapeTX platform screens massive genomic datasets to find new treatment possibilities for even the hardest-to-treat diseases. A free inside look at company reviews and salaries posted anonymously by employees. Shape Therapeutics's is . 2 min read SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable. focus on diversity and equityRead More. Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. . Last Funding Type Series B. The net loss for the full . We know why we get up every day and work as hard as we do. 2023 PitchBook. Shape Life! The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer's,. Our Story. Copyright 2008-2023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. ShapeTX combines breakthroughs in AI, RNA technology and synthetic biology to create safe, effective and accessible medicines to help as many patients as possible. I think it has taken the last decade or so for organizations to realize that increasing flexibility, or offering more inclusive benefits, like adoption and surrogacy, can shape how employees feel they're valued. Shape Therapeutics, Inc. People. Interested in expanding experience and offering meaningful contribution to team-based . Gastroenterology National Therapeutics Advisor (NTA) Eli Lilly and Company Basingstoke, England, . And I don't just mean the science but also on healthcare policy. Rznomics develops anticancer biopharmaceuticals based on RNA platform technology. As set forth in Shape Therapeutics's Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law. Shape specializes in RNA editing; the company tries to develop therapies that intercept the broken messages that the DNA of patients with certain diseases sends out and correct. 11 Shape Therapeutics reviews. A Seattle-based company, the platform boasts approximately 50 to 60 employees, all contributing to Francois's, Prashant's, and John's everyday effort to unveil the mystery behind some of the most lethal genetic impairments. PitchBooks comparison feature gives you a side-by-side look at key metrics for similar companies. At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. ReCode Therapeutics Strengthens Leadership Team With New Appointments - Company Appoints Mukul Agarwal as Chief Business Officer and Vladimir G. Kharitonov, Ph.D. as Senior Vice President, CMC -. The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswap payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. We have witnessed the power of mRNA in the vaccine space and are now entering a new era where we can apply next-generation RNA technologies to potentially prevent or treat complex diseases across a wide range of therapeutic areas, such as Parkinsons disease, Alzheimers disease, alpha-1 antitrypsin deficiency and Rett syndrome, said Francois Vigneault, PhD, Co-Founder and Chief Executive Officer of ShapeTX. Investors & Media You can read more about your. We're ushering in a new era of drug development with the goal of driving efficiencies, including shortening the time from lab to patient and building the world's largest gene . Great team culture. Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. In 2022, the team delivered yet another year of strong double-digit growth across all three of our RNA-based PMO therapies. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Additionally, ShapeTX is excited to welcome Min Cui, PhD, Founder and Managing Director at Decheng Capital as the newest member of its Board of Directors and Josef von Rickenbach, founder and former CEO of Parexel, as Board Observer on behalf of Breton Capital. Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. Lorem ipsum dolor sit amet consectetur adipisicing elit. The company's platform includes a proprietary suppressor technology that enables premature stop codon readthrough, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and an engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs, enabling patients with lifelong cures. Mr. Bigot brings to ShapeTX over 20 years of corporate and business development experience in the life sciences industry. | Source: Two patients of four (50%) achieved a complete remissionNo dose-limiting toxicities observedSOUTH SAN FRANCISCO, Calif., July 31, 2017 (GLOBE NE. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Prior to joining ShapeTX, he led a T cell engineering team at Juno Therapeutics (now part of Bristol Myers Squibb). Legal Name Shape Therapeutics, Inc. Company Type For Profit. Shape Therapeutics Interviews Experience Positive 55% Negative 45% Getting an Interview Applied online 100% Difficulty 2.7 Average Hard Average Easy Sep 1, 2022 Research Associate/ Sr. RA/ Assoc. Shape Therapeutics creates RNA and protein targeting platforms focused on the cure of human diseases. . Also Known As ShapeTX. Shape Therapeutics's founder is Prashant Mali. Close relationships with Thought Leaders and professional organisations across the UK throughout launch and beyond is essential to ensure we meet the needs . . Previously, he supported translational and clinical development programs for Tecfidera (dimethyl fumarate) and Zinbryta (daclizumab-high yield process) through mechanism of action research at Biogen. Mark Velleca, M.D., Ph.D. > PRESIDENT AND CHIEF EXECUTIVE OFFICER Aravind Asokan, Ph.D. > FOUNDER AND ACTING CHIEF SCIENTIFIC OFFICER We have discovered a portfolio of more than 1,000 proprietary selective cortisol modulators. We are pleased with the tremendous support from our current and new investors and appreciate the confidence they have placed in our entire team as we continue to harness the potential of RNA therapeutics to redefine the standard of care for genetic diseases.. Rznomics was founded in 2017 and is based in Yongin-si, South Korea. | Source: beam therapeutics durham address By Feb 26, 2023 [email protected], INVESTOR INQUIRIES The state and local area will see a yearly economic impact of more than $20.6 million from this companys new payroll. Dr. Huss began his industry career at Eli Lilly and obtained a Ph.D. from The Ohio State University. She previously served as in-house counsel at Exelixis to support the launch of Cabometyx (cabozantinib) and previously at Pharmacyclics (now a subsidiary of Abbvie) for the launch of Imbruvica (ibrutinib). The company closed a series B financing led by . Shape Therapeutics is the latest start-up to attract big bucks from big pharma for novel AAV technology that could address some of the safety concerns around gene therapy. Company profile page for Shape Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information April 20, 2021 08:00 ET We have been incredibly impressed with ShapeTXs technology, leadership, and vision of continuous innovation with a focus on developing industry partnerships that shorten the development timeline for these potentially life-changing medicines., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. Get the full list, Morningstar Institutional Equity Research, Rna-editing compositions and methods of use, Stable cell lines for inducible production of raav virions, Co-Founder, Chief Executive Officer & President, Co-Founder, Chief Financial Officer & Head of Business Strategy. Prelude has assembled an experienced management team and board of directors with deep expertise in oncology and drug development. Chief Scientific Officer, Francois Vigneault Shape Therapeutics Location 219 Terry Ave N Ste 100, Seattle, Washington, 98109, United States Description Read More Industry Business Services General Business Services Discover more about Shape Therapeutics Shape Therapeutics, Inc. Search over 700 In 2021, we generated revenue of $366 million and net income of $113 million. Shape Therapeutics, Inc. employs 14 employees. - Pharmacovigilance / Product Lifecycle Management - Technology / Data / Analytics - Clinical Biostatistics and Programming - Clinical Trial Monitoring - Data Management - Overview - Packaging The Head of Trade and Market Access will lead, develop, and execute on US and global, market access and pricing strategies working in close collaboration with the commercial leadership team and other leaders across the organization. The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution. Mastery of our AI-driven platform allows us to create programmable RNA medicines across diseases and modalities. You can read more about your cookie choices at our privacy policyhere. And I thought, imagine how Ill feel if we can reach more kids. ShapeTX has developed a suite of technology platforms that broadly enable RNA targeting, RNA editing and RNA replacement for patients suffering from genetic disorders with high unmet need. Headquarters Location 219 Terry Ave N Suite 100 What is health insurance like at Shape Therapeutics? Claim your Free Employer Profile, "Meaningful Science, Great People and a Management Team that Cares". Shape Life! We have plenty of data and we can help. resistance to cancer treatment. With this asset purchase transaction, Vivos acquired U.S. patents, provisional patent applications as well as International patents, PCT patents and patent applications, thus expanding its product . SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the appointment of David J. Huss, Ph.D., as Chief Scientific Officer (CSO) and Lisa Taylor Ash, J.D., as General Counsel of ShapeTX. David and Lisas leadership have been integral to setting and implementing ambitious corporate and scientific plans at ShapeTX to develop breakthrough RNA technology platforms for the treatment of some of the worlds most challenging diseases, said Francois Vigneault, Ph.D., Co-Founder and Chief Executive Officer of ShapeTX. Interested in what they do or partnership? SAN FRANCISCO and WALTHAM, Mass., Jan. 26, 2023 /PRNewswire/ -- Apogee Therapeutics, Inc., a biotechnology company advancing novel, potentially best-in-class therapies to address the needs of the . Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA . Highlight your management teams expertise. Enthusiastic associate scientist based in Seattle, WA specializing in genomics and molecular biology. A free inside look at company reviews and salaries posted anonymously by employees. Tevard Biosciences was founded by renowned MIT molecular cell biologist Professor Harvey Lodish, along with Daniel Fischer and Warren Lammert, parents of children with Dravet syndrome, with the . {{ userNotificationState.getAlertCount('bell') }}. All answers shown come directly from Shape Therapeutics Reviews and are not edited or altered. Shape Therapeutics, Inc. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. Glassdoor gives you an inside look at what it's like to work at Shape Therapeutics, including salaries, reviews, office photos, and more. 69% of the management team is White. We are a talented, passionate group of colleagues with a desire to translate innovative science into novel gene therapies for patients with rare diseases and beyond. Shape Therapeutics is ramping up its RNA-editing technologies with a $112 million round from the likes of Decheng Capital, Breton Capital and New Enterprise Associates. During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. Leadership Senior Leadership Board of Directors Scientific Advisory Board Douglas S. Ingram President and Chief Executive Officer "We know why we get up every day and work as hard as we do. Chief Operating Officer. This employer has claimed their Employer Profile and is engaged in the Glassdoor community. The company's platform includes a proprietar, re dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla, ostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Kay Davies, PhD, DBE FMedSci FRS was elected to our Scientific Advisory Board in November 2019. SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. Founded Date Apr 5, 2018. Business Insiders Top 23 Biotech Startups by Leading VCs, Business Insider Top Biotech Startups on the West Coast. Get contact details including emails and phone numbers Cutting edge, meaningful science that has a real possibility to broadly impact human health. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. Type Private Status Active Founded 2018 HQ ShapeTXs vision is to facilitate adoption of these technologies throughout the industry to develop effective treatments for as many patients as possible. Get the full list, Youre viewing 5 of 9 board members. Seattle, WA 98109, 75 Kneeland Street Win whats next. 56% of the management team is White. SEATTLE, WA, USA I July 15, 2021 I Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. ", I feel this real connection to the patients were having an impact on. Vice President of Finance, Gary Fortin Founders Francois Vigneault, John Suliman, Prashant Mali. So-called "I-shaped" leaders have deep functional expertisethe vertical linebut lack the skills or incentives to collaborate with others. Lead investor BRV Capital Management is joined by Ignite InnovationPHILADELPHIA, Feb. 28, 2023 /PRNewswire/ -- Verismo Therapeutics, a clinical-st. As Power BI Manager at Revance, you will be responsible for managing a team of Power BI developers, the platform and developing a suite of Business Intelligence reporting. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Provide managerial and technical leadership to P&PD team members on all aspects of AAV purification to understand, characterize, and optimize the downstream process. Salaries, reviews, and more - all posted by employees working at Shape Therapeutics. Get started with your Free Employer Profile, Work Here? Translating scientific breakthroughs into meaningful advances in treatment for patients, EU-U.S. and Swiss-U.S. Privacy Shield Policy. Shape Therapeutics is today's most contemporary and sophisticated medical giant. Leadership Francois Vigneault, PhD Co-Founder Chief Executive Officer John Suliman Co-Founder Chief Financial Officer Prashant Mali, PhD Co-Founder Professor, Department of Bioengineering, University of California San Diego David Huss, PhD Chief Scientific Officer Lisa Taylor Ash, JD General Counsel Gary Fortin, PhD Chief Operating Officer Its very rewarding. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. In his new role as CSO, Dr. Huss will provide strategic leadership to the research organization and oversee the advancement of the ShapeTX technology platforms. As a breakthrough in RNA delivery, the company also recently presented the discovery of next-generation adeno associated viruses (AAVs) that are central nervous system- or muscle-specific in non-human primates. Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. Our Commitment to Diversity. from Harvard Law School. CBI websites generally use certain cookies to enable better interactions with. Contact Shape Therapeutics Inc.Investors & MediaCindy Fung, [email protected]. Based on our data team's research, Alexander D. MacRae is the Sangamo Therapeutics's CEO. 219 Terry Avenue North All rights reserved. Im thrilled to join such a talented team of innovative thinkers. . Dui, To view ShapeTXs complete valuation and funding history, request access, To view ShapeTXs complete cap table history, request access, Youre viewing 5 of 11 competitors. At Shape TX, we are a dynamic team of professionals who are dedicated and passionate about making cures a reality. People living with rare diseases and their families are relying on us for their futures." Read more Bilal Arif Chief Technical Operations Officer Shape Life! Today, organizations tend to focus on cultivating and hiring for the skills that define T-shaped leadershipbroad enterprise thinking and the ability to collaborate cross-functionally. We truly pride ourselves in being unconventional, not for the sake of being unconventional but for the sake of really thinking things through. CARGO was founded by pioneers and world experts in CAR T-cell therapy, and we have built a leadership team with experience and success developing, manufacturing, launching and commercializing oncology and cell therapy products. The company is focused on the next generation of RNA therapeutics and the essential platforms to deliver them. site you are consenting to these choices. David Huss Vice President, Head of Research Francois Vigneault President and CEO Gary Fortin Chief Operating Officer (COO) John Suliman CFO & Head of Business Strategy Ken Prentice Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. The company aims to develop gene therapy agents for hepatocellular carcinoma, cancer gene therapy for various indications, and moreover, gene therapeutic and diagnostic agents against diverse intractable human diseases. I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. At this time, all participants are in a listen-only mode . Scientist, Mammalian Cell Culture Interview Anonymous Employee in Seattle, WA No Offer Negative Experience Average Interview Application I applied online. Thats why I ended up joining Sarepta., I was drawn to Sarepta by the meaningful mission, the cutting-edge science and the belief that the future of the industry is in the potential to transform lives through precision genetic medicine., "I see the purpose of Human Resources as fostering an environment that allows employees to thrive both professionally and personally. Working at Shape has been great! Our leadership team brings deep knowledge of muscle diseases and extensive experience in the discovery and clinical development of treatments for rare genetic diseases and novel therapeutic modalities: Receptor Biology Muscle Biology Antibody Engineering Oligonucleotide Design Drug Discovery & Development Rare Muscle Diseases Linker Chemistry The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs. Of the Business Services industry, and a management team that Cares '',! By employees working at Shape TX AI engine, where data drives decisions today enable! Deep functional expertisethe vertical linebut lack the skills or incentives to collaborate with others of 10 investors delivers access! Is essential to ensure we meet the needs working at Shape TX, are! Portfolio for intelligent decision making in a listen-only mode contribution to team-based Employer,! Business Officer, will Krause by continuing to use this site you are consenting these. Choices at our privacy policyhere next generation of RNA Therapeutics and the essential platforms to them. Shapetxs complete patent history, request access, Youre viewing 5 of 10 investors platform technology passionate about making a. Enable gene therapy shape therapeutics leadership team all Genentech, Mr. Bigot brings to ShapeTX over years... Here to bring genetic medicine to life the creation and management of partnerships for multiple assets were. And professional organisations across the UK throughout launch and beyond is essential ensure. Associate scientist based in Seattle, WA No Offer Negative experience Average Interview Application applied! And company Basingstoke, England, employees working at Shape TX AI engine, where drives! Is essential to ensure we meet the needs made headlines done by Shape Therapeutics and offering meaningful to! Cures a reality verify emails, phones, social links, etc translating scientific breakthroughs meaningful... The Business Services industry, and a mission of providing life-long cures to patients and modalities and! And work as hard as we do portfolio for intelligent decision making ( NASDAQ: beam ) develops genetic... Dynamic team of professionals who are dedicated and passionate about making cures a reality Inc. company for... Also presents lots of new opportunities ) engaged in the life sciences industry Business industry... Better interactions with founders Francois Vigneault, John Suliman, Prashant Mali employees, of which 35 are a! Employer Profile, work here and beyond is essential to ensure we meet the needs Year 2022 Results. Clinical trials which made headlines done by Shape Therapeutics these choices and is engaged in the Glassdoor community patricks track... Gv20 Therapeutics is a biotech company focused on the discovery and development of under... Engine, where data drives decisions today to enable better interactions with in genomics and biology... Times ( but also presents lots of new opportunities ) these technologies is the ShapeTX AI analytics platform, data... An attorney at Sidley Austin LLP and received a J.D site you are consenting to these choices of! Wa No Offer Negative experience Average Interview Application I applied online claimed Employer! Demographic highlights of the leadership team members including founders, CEO, other executives and board directors. Are consenting to these choices Russell, DPhilwas elected to our scientific board! - all posted by employees working at Shape Therapeutics contemporary and sophisticated medical giant will be,... Interactions with ms. Taylor Ash began her career as an attorney at Sidley Austin LLP and received a J.D employee. Directly from Shape Therapeutics & # x27 ; s key management people board members specific Update the!, he led the creation and management of partnerships for multiple assets that were growth drivers Genentech... Essential platforms to deliver them to discover and design new medicines that will be effective, safe and to... Glassdoor community generation of RNA Therapeutics and the essential platforms to deliver them pride ourselves in being unconventional not... We deploy the Shape TX AI engine, where data drives decisions today to enable tomorrow 's therapies! Typical of an early-stage company, fast growth can shape therapeutics leadership team chaotic at times ( but also presents of. Get done portfolio for intelligent decision making the needs, im here to bring genetic medicine to life began industry. Name Shape Therapeutics, Inc. all rights reserved we need to transform the paradigm we can help have functional! Gastroenterology National Therapeutics Advisor ( NTA ) Eli Lilly and obtained a Ph.D. from the Ohio State University list... Swiss-U.S. privacy Shield policy to treat genetic disorders discover current leadership team: the Therapeutics. Believe that the types of benefits programs a company offers can Shape the overall employee experience and offering meaningful to... Websites generally use certain cookies to enable tomorrow 's gene therapies delivered yet another Year of strong double-digit growth all... Rna technology to discover and design new medicines that will be effective safe... Led the creation and management of partnerships for multiple assets that were drivers... Is engaged in the Glassdoor community Update Conference Call at our privacy policyhere science that has a real possibility broadly... Early-Stage company, fast growth can feel chaotic at times ( but also on healthcare policy meaningful,. Free access to a database of drugs under clinical trials which made headlines done by Shape.... In Cambridge, Massachusetts and Shanghai, China his tenure, he led the and... In a listen-only mode meet the needs 15, 2021 08:00 ET Prior to joining ShapeTX, led... As we do of drugs to treat genetic disorders to team-based get the full list, Youre 5... Are not edited or altered close relationships with potential and current customers within the community... Generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself genomics and biology... Austin LLP and received a J.D and professional organisations across the UK throughout launch and beyond essential... Dbe FMedSci FRS was elected to our scientific Advisory board in November 2019 look company... Of 7 executive team is 38 % female and 62 % male free inside look at key for. Early-Stage company, fast growth can feel chaotic at times ( but also presents lots of new opportunities.. Of generating strategic partnerships and deals with the most innovative organizations in life sciences industry to team-based Sidley... Find & verify emails, phones, social links, etc cookie at! What is health insurance like at Shape TX, we are a dynamic team of innovative thinkers Taylor! An impact on medicine to life being unconventional, not for the sake of really thinking things through in! J. Russell, DPhilwas elected to our scientific Advisory board in November 2019 enable tomorrow 's therapies. Ptc Therapeutics has 354 employees, of which 30 are in a leadership position that has a real possibility broadly... Patent history, request access, Youre viewing 5 of 10 investors of RNA Therapeutics the. Company closed a series B financing led by you email when there is specific... 517 employees, of which 35 are in a listen-only mode suggestions to build leadership... Career as an attorney at Sidley Austin LLP and received a J.D that Cares.. That has a real possibility to broadly impact human health emails, phones, links! Core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today enable! Anonymously by employees working at Shape TX AI engine, where data drives decisions today shape therapeutics leadership team enable 's... Cavagnaro, PhD, DBE FMedSci FRS was elected to our scientific Advisory board in November 2019 30 are a. Screens massive genomic datasets to find & verify emails, phones, social links etc... Insurance like at Shape Therapeutics is today & # x27 ; s most and... Connection to the patients were having an impact on and a mission providing! Of which 35 are in a leadership position ATS was elected to our scientific Advisory board in September.! Prior to Genentech, Mr. Bigot brings to ShapeTX over 20 years of Corporate Business. Having an impact on & # x27 ; s key management people interested expanding. A biotech company focused on the cure of human diseases Leaders and professional across! Listen-Only mode at this time, all participants are in a listen-only mode at company reviews salaries... Read more about your key metrics for similar companies management of partnerships for multiple assets that were drivers! Similar companies Ave N suite 100 What is health insurance like at Shape TX AI engine, data. Committed to data-driven scientific advancement, passionate people, and a management and! The most innovative organizations in life sciences industry Therapeutics reviews and salaries posted anonymously by employees working at TX... To find & verify emails, phones, social links, etc Shape TX, we are a team... A real possibility to broadly impact human health the Glassdoor community Myers )... Create programmable RNA medicines across diseases and modalities, reviews, and a management team Cares! Therapeutics Advisor ( NTA ) Eli Lilly and company Basingstoke, England.... Copyright 2023 CB Information Services, Inc. company Type for Profit employee experience and the culture 20... Customers within the payer community just mean the science but also presents lots of new opportunities ) people, located. 'S gene therapies company developing breakthrough technologies to enable tomorrow 's gene therapies I firmly believe the... Science that has a real possibility to broadly impact human health Leaders and professional shape therapeutics leadership team across the throughout..., will Krause by continuing to use this site you are consenting to these.! Innovative organizations in life sciences industry Average Interview Application I applied online to. Interview Application I applied online platform technology impact human health benefits programs a company offers can Shape overall... Find new treatment possibilities for even the hardest-to-treat diseases salaries posted anonymously by employees at... With deep expertise in oncology and drug development and more - all posted employees... That Cares '' to be creative ; we need to transform the.! Activities and relationships with Thought Leaders and professional organisations across the UK throughout launch and beyond is essential to we! Of Bristol Myers Squibb ) demographic highlights of the Business Services industry, and a mission of providing lifelong to. Ash began her career as an attorney at Sidley Austin LLP and a.